Angiotensin II: An insulin-sensitizing vasoactive hormone?

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 4, 1996, Pages 1303-1306

  Morris, Andrew D ^a   Donnelly, Richard ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; BRADYKININ; CALCIUM ION; CAPTOPRIL; CARBOHYDRATE; CATECHOLAMINE; CATHEPSIN G; CYCLIC AMP; DIACYLGLYCEROL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTASE; ENALAPRIL; GLUCOSE; HORMONE; INSULIN; KALLIKREIN; LIPID; PROTEIN KINASE C; RENIN; TISSUE PLASMINOGEN ACTIVATOR; ANGIOTENSIN II; VASOCONSTRICTOR AGENT;

BLOOD FLOW; BLOOD PRESSURE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; DOSE RESPONSE; ENZYME ACTIVITY; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; BLOOD VESSEL; DRUG EFFECT; HEART; HEMODYNAMICS; KIDNEY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; BLOOD VESSELS; DIABETES MELLITUS, TYPE 2; HEART; HEMODYNAMIC PROCESSES; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTOR AGENTS;

EID: 0029870663     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.4.1303     Document Type: Review

References (40)

1. Ganten D, Mullins J, Lindpainter K. 1989 The tissue renin-angiotensin system: a target for angiotensin converting enzyme inhibitors. J Hum Hypertens. 3:63-70.
2. Dzau VJ. 1990 Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens. 7:933-936.
3. Weidmann P, Ferrari P, Shaw SG. 1993 Renin in diabetes mellitus. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical; 75.2-75.26.
4. De Witt LM, Putney JW. 1983 Stimulation of glycogenolysis in hepatocytes by angiotensin II may involve both calcium release and calcium influx. FEBS Lett. 160:259-263.
5. Kneer NM, Lardy HA. 1983 Regulation of gluconeogenesis by norepinephrine, vasopressin and angiotensin II: a comparative study in the absence and presence of extracellular calcium. Arch Biochem Biophys. 225:187-195.
6. Herings RMC, de Boer A, Stricker BHCH, Leufkens HGM, Posius A. 1995 Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 345:1195-1198.
7. Vuorinen-Markkola H, Yki-Jarvinen H. 1995 Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin dependent diabetes mellitus. Metabolism. 44:85-89.
8. Townsend RR, Klein S, Wolfe RR. 1994 Changes in lipolytic sensitivity following repeated epinephrine infusion in humans. Am J Physiol. 266:E244-E260.
9. Shamiss A, Carroll J, Rosenthal T. 1992 Insulin resistance in secondary hypertension. Am J Hypertens. 5:26-28.
10. Townsend RR, Zhao HW. 1994 Plasma-renin activity and insulin sensitivity in normotensive subjects. Am J Hypertens. 7:894-898.
11. Jauch KW, Hartl W, Guenther B, Wicklmays M, Rett K, Dietze G. 1987 Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 17:448-454.
12. Townsend RR, DiPette D. 1993 Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol. 265:E362-E366.
13. Buchanan TA, Thawani H, Kade W, et al. 1993 Angiotensin II increases glucose utilization during acute hyperinsulinaemia via a hemodynamic mechanism. J Clin Invest. 92:720-726.
14. Morris AD, Petrie J, Anderson J, Connell JMC, Donnelly R. 1993 The effects of angiotensin II on insulin sensitivity: a placebo-controlled study. Clin Sci. 85:431-436.
15. Townsend RR, DiPette D, Lieux TR, Wolfe RR. 1993 The role of the renin angiotensin system in insulin sensitivity in normotensive subjects. Am J Med Sci. 305:67-71.
16. Widgren BR, Urbanavicius V, Wikstrand J, Attval S, Persson B. 1993 Low-dose angiotensin II increases glucose disposal rate during euglycemic hyperinsulinaemia. Am J Hypertens. 6:892-895.
17. Fliser D, Arnold U, Kohl B, Hartung R, Ritz E. 1993 Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycaemic conditions. J Hypertens. 11:983-988.
18. Morris AD, Petrie J, Ueda S, et al. 1994 Angiotensin II increases insulin sensitivity in non-insulin dependent diabetes: dissociation of metabolic and blood pressure effects. Diabetes. 43:1445-1449.
19. Shultz TA, Lewis SB, Westbie DK, Wallin JD. 1977 Glucose delivery: a modulator of glucose uptake in contracting skeletal muscle. Am J Physiol. 2:E514-E518.
20. Baron AD, Brechtel G. 1993 Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol. 265:E61-E67.
21. Laakso MS, Edelman S, Brechtel G, Baron AD. 1992 Impaired insulin mediated skeletal muscle blood flow in patients with non-insulin dependent diabetes mellitus. Diabetes. 41:1076-1083.
22. Baron, A.D. 1994 Hemodynamic actions of insulin. Am J Physiol. 267:E187-E202.
23. Julius S, Gudbrandsson T, Jamieson K, Shabab ST, Andersson O. 1991 The haemodynamic link between insulin resistance and hypertension. J Hypertens. 9:983-986.
24. Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH. 1994 Relation of pressor responsiveness to angiotensin-II and insulin-resistance in hypertension. J Clin Invest. 94:2295-2300.
25. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. 1994 Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest. 94:1172-1179.
26. Laakso MS, Edelman S, Brechtel G, Baron AD. 1990 Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest. 85:1844-1852.
27. Honig CR, Odoroff CL, Frierson JL. 1982 Active and passive capillary control in red muscle at rest and in exercise. Am J Physiol. 243:H196-H206.
28. Renkin EM. 1983 Control of microcirculation and blood-tissue exchange. In: Renkin EM, Michel CC, eds. Handbook of physiology. The cardiovascular system: microcirculation. Bethesda: American Physiology Society; vol 4:627-687.
29. Caro CG, Pedley TJ, Scroter RC, Seed WA. 1978 The mechanics of the circulation. New York: Oxford University Press; 418-422.
30. Vicaut E, Montalescot G, Hou X Stucker O, Teisseire B. 1989 Arteriolar vasoconstriction and tachyphylaxis withy intra-arterial angiotensin II. Microvasc Res. 37:28-41.
31. Vicaut E, Hou X. 1993 Arteriolar constriction and local renin-angiotensin system in rat microcirculation. Hypertension. 21:491-497.
32. Christlieb AR. 1976 Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 25:268-274.
33. Whitbread S, Mele M, Kamber B, de Gasparo M. 1989 Preliminary biochemical characterisation of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 163:284-291.
34. Smrcka AV, Helper JR, Brown KO, Sternweis P. 1991 Regulation of polyphosphoinositide specific phospholipase C activity by purified Gq. Science. 251: 804-807.
35. Exton JH. 1980 Mechanisms involved in alpha-adrenergic phenomena: role of calcium ions in actions of catecholamines in liver and other tissues. Am J Physiol. 238:E3-E12.
36. + -sensitive protein kinases in the response of hepatocytes to angiotensin II and vasopressin. J Biol Chem. 259:3283-3292.
37. + linked hormones angiotensin-II, norepinephrine, and vasopressin stimulate the phosphorylation of distinct substrates in intact hepatocytes. J Biol Chem. 257:3135-3143.
38. Considine RV, Caro JF. 1993 Protein kinase C: mediator or inhibitor of insulin action? J Cell Biochem. 52:8-13.
39. Donnelly R, Reed MJ, Azhar S, Reaven GM. 1994 Expression of the major isoenzyme of protein kinase C in skeletal muscle, PKC-θ, varies with fiber-type composition and in response to fructose induced insulin resistance. Endocrinology, 135:2369-2374.
40. Cassis LA. 1992 Down-regulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol. 262:E105-E109.